title: Vaccination: A durable design.
authors.forename: Katharine
authors.initials: K
authors.lastname: Sanderson
mesh_terms: D000956:Antigens, Viral / Q000276:immunology; D003906:Developing Countries / Q000191:economics / Q000706:statistics & numerical data; D015195:Drug Design; D004356:Drug Storage; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D016233:Immunotherapy, Active; D027383:Papillomaviridae / Q000145:classification / Q000276:immunology / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000191:economics / Q000276:immunology / Q000600:supply & distribution / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000191:economics
chemical_list: D000956:Antigens, Viral; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18